(NASDAQ: JBIO) Jade Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.72%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.85%.
Jade Biosciences's earnings in 2025 is -$48,960,000.On average, 2 Wall Street analysts forecast JBIO's earnings for 2025 to be -$24,408,438, with the lowest JBIO earnings forecast at -$33,125,720, and the highest JBIO earnings forecast at -$15,691,157. On average, 2 Wall Street analysts forecast JBIO's earnings for 2026 to be -$13,657,072, with the lowest JBIO earnings forecast at -$19,759,161, and the highest JBIO earnings forecast at -$7,554,983.
In 2027, JBIO is forecast to generate -$20,340,351 in earnings, with the lowest earnings forecast at -$20,340,351 and the highest earnings forecast at -$20,340,351.